Karen Bracken

Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial

Gary Wittert, Karen Bracken, Kristy Robledo et al. · The Lancet Diabetes & Endocrinology · 2020 · 334 citations

Metabolic Syndrome, Diabetes Management, Andrology +7

Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: A 2-Year RCT

Mark Ng Tang Fui, Rudolf Hoermann, Karen Bracken et al. · The Journal of Clinical Endocrinology & Metabolism · 2021 · 62 citations · Full text

Testosterone therapy to prevent type 2 diabetes mellitus in at‐risk men (T4DM): Design and implementation of a double‐blind randomized controlled trial

Gary Wittert, Evan Atlantis, Carolyn A Allan et al. · Diabetes Obesity and Metabolism · 2018 · 37 citations

Recruitment of men to a multi-centre diabetes prevention trial: an evaluation of traditional and online promotional strategies

Karen Bracken, Wendy Hague, Anthony Keech et al. · Trials · 2019 · 32 citations · Full text

Preliminary results from a phase II trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations

Alan L. Ho, Nicole G. Chau, Jessica R. Bauman et al. · Annals of Oncology · 2018 · 24 citations · Full text